[18F]FET-PET Imaging for Treatment and Response Monitoring of Radiation Therapy in Malignant Glioma Patients – A Review
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 3, 104
Abstract
In the treatment of patients suffering from malignant glioma, it is a paramount importance to deliver a high radiation dose to the tumor on the one hand and to spare organs at risk at one the other in order to achieve a sufficient tumor control and to avoid severe side effects. New radiation therapy techniques have emerged like intensity modulated radiotherapy (IMRT) and image guided radiotherapy (IGRT) that help facilitate this aim. In addition, there are advanced imaging techniques like PET and PET/CT which can help localize the tumor with higher sensitivity, and thus contribute to therapy planning, tumor control and follow up. During follow up care, it is crucial to differentiate between recurrence and treatment-associated, unspecific lesions, like radiation necrosis. Here, too, PET/CT can facilitate in differentiating tumor relapse from unspecific changes. This review article will discuss therapy response criteria according to the current imaging methods like MRI, CT and PET/CT. It will focus on the significance of PET in the clinical management for treatment and follow up.Keywords
This publication has 78 references indexed in Scilit:
- Advanced MRI and PET imaging for assessment of treatment response in patients with gliomasThe Lancet Neurology, 2010
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Pseudoprogression and pseudoresponse in the treatment of gliomasCurrent Opinion in Neurology, 2009
- Reply: Brain SPECT by 99mTc-Tetrofosmin for the Differentiation of Tumor Recurrence from Radiation InjuryJournal of Nuclear Medicine, 2008
- Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After RadiotherapyJournal of Nuclear Medicine, 2008
- Glioma Proliferation as Assessed by 3‘-Fluoro-3’-Deoxy-l-Thymidine Positron Emission Tomography in Patients with Newly Diagnosed High-Grade GliomaClinical Cancer Research, 2008
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomasBrain, 2005
- Cerebral Radiation NecrosisThe Neurologist, 2003
- “Facilitated” Amino Acid Transport is Upregulated in Brain TumorsJournal of Cerebral Blood Flow & Metabolism, 1998